Mikhail Blagosklonny: Quest to Turn the Anti-Aging Drug into Reality

A new theory came out recently stating that aging is a process of continuous growth, and rapamycin, which is a substance known for cancer treatment, can treat aging if given in proper doses and schedules. Rapamycin can also treat sickness and diseases by making the immunity stronger, and it is also possible that the substance can prolong human life. It has been believed for many years that aging is caused solely by our degenerating cells, and nothing can stop or prevent it. This new milestone in the field of medicine could rewrite humankind’s history, as our quest for immortality is slowly becoming a possibility. This immortality theory using rapamycin as its central idea is initially ridiculed by scientists worldwide. However, five years later, as more and more studies are conducted, they slowly realized that this is not just another case of “fantasy” theory, but there is indeed a basis for it to be applicable in real life. Dr. Mikhail Blagosklonny is the scientist who proposed this theory, and he has been sacrificing his time and resources to find out how he can turn his drug into a reality. He is very passionate about being credited as the first man to introduce a drug that provides human immortality. He does not stop from where he is currently right now, but still, conducts researches and studies to gather more proof as to how effective the drug could be. Dr. Mikhail Blagosklonny is a proud graduate of First Pavlov State Medical University of St. Petersburg, where he received his MD and Ph.D. Right after receiving his degrees, he decided to teach at Roswell Park Cancer Institute as a professor of oncology, and he was loved and remembered by his students as the teacher who aims to bring change to the world through introducing discoveries that would benefit humanity. Visit classroomvoices.org to read more about Mikhail.

The hypothesis that was formulated by Dr. Mikhail Blagosklonny explains the primary role of target of rapamycin. It was stated that the aging process and the formulation of cancer have a common denominator – signals coming from rapamycin. Based on the research that they have been conducting, two centric models coming from a rapamycin sample is the one who would stop aging – MTOR and TOR. The TOR Centric Model is found in three sources – genetics, cellular senescence, and diseases, while the MTOR Centric Model is found in different areas, which is not constant.

Dr. Mikhail Blagosklonny is working day and night to finalize a prototype drug that they are planning to introduce to the public, and see if it will become successful without any side effects. This quest for immortality has been highlighted in several news reports, and other companies such as Novartis is taking advantage of the research and is now manufacturing their version of immortality drug. Humans have been fascinated by the idea of immortality even in the ancient times, and they will never stop until the day comes that they can finally live forever. In our world today, it is just a matter of “when,” rather than an “if.” This product of fantasy and science fiction could one day become a reality, thanks to Dr. Mikhail Blagosklonny. Read more on templeofthecave.com

Oncotarget: Transforming Oncology Through Research

One of the main goals of Oncotarget is to redefine the world of Oncology with research. They have a fully competent system which enables them to do just that. They recently announced that the Oncotarget journal was recently voted number one among all journals based on Oncology research. The knowledge and experience of their research professionals has definitely paid off.

What are some things that set Oncotarget apart? How are they working to be an asset to the Cancer research community and to Cancer patients? The answer first and foremost lies in their vision statement, which is the guiding force of every company. At Oncotarget, they seek to “make scientific results rapidly and widely available” and “to maximize the impact of research via insightful review.” They are also looking to link different specialties together and to join different biomedical fields together in order to create a more cohesive unit in the fight against Cancer.

Download: http://endnote.com/downloads/style/oncotarget

Right down to their name, this is an organization that is seeking to redefine Cancer research. They are proud of telling people that the term ‘Oncotarget” is simply the study of “all molecules, pathways, and cellular functions common in cancer and aging, neurodegeneration and atherosclerosis, lymphocytes and neurons, cancer cells and microbes.” Because they realize that cancer has destroyed many lives, their studies encompass a lot of different areas.

One of their most notable areas would be in the realm of Asbestos. Many men and women have been diagnosed with cancer simply because they were working with this chemical day in and day out. Oncotarget’s recent research uncovered the fact that there were certain properties in some of the cancer cells of the Asbestos-related cancer Malignant mesothelioma (MM) that can make early diagnosis much easier. Ask any Asbestos Cancer patient or physician treating them, and they would tell you that early diagnosis sometimes is the difference between life and death. Oncotarget is also available on Dove Press.

It is these breakthroughs that Oncotarget continues to do on a daily basis. They work tirelessly to redefine research and make literally millions of individual lives better. Research from dedicated scientists makes everything possible!